Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd. (SHA:603707)

China · Delayed Price · Currency is CNY

9.85

-0.09 (-0.91%)

Mar 19, 2026, 1:24 PM CST

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Standard heparin API	787.14M	-	-	-						416.09M
Standard heparin API Growth	-	-	-	-						4.50%
Pharmaceutical Preparations	3.05B	-	-	-						-
CDMO and Other Products	80.32M	-	-	-						-
Other	5.86M	-	-	-						10.49M
Other Growth	-	-	-	-						128.52%
Low Molecular Weight Heparin Preparations	-	-	-	-						5.96M
Heparin Preparation	-	-	-	-						29.42M
Heparin Preparation Growth	-	-	-	-						7367.11%
Total	3.92B	-	-	-						461.96M
Total Growth	-	-	-	-						14.59%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
China	916.52M	-	-	-						43.71M
China Growth	-	-	-	-						118.53%
Foreign	3.01B	-	-	-						-
North America	-	-	-	-						282.39M
North America Growth	-	-	-	-						100.78%
Europe	-	-	-	-						101.37M
Europe Growth	-	-	-	-						-36.35%
South America	-	-	-	-						33.32M
South America Growth	-	-	-	-						-59.34%
Asia	-	-	-	-						1.17M
Asia Growth	-	-	-	-						-9.10%
Total	3.92B	-	-	-						461.96M
Total Growth	-	-	-	-						14.59%

Source: S&P Global Market Intelligence.